US equities |
MU $904.90 ▲+2.97% NVDA $217.09 ▲+1.38% AMZN $262.45 ▲+4.98% TSLA $368.06 ▲+3.76% AAPL $342.94 ▼-0.15% SNDK $1,371.12 ▲+5.53% META $705.44 ▼-0.55% SPCX $147.96 ▲+1.32%
FinancialContent

Articles published by Plandai Biotechnology

News headline image
Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
From Plandai Biotechnology
Via AccessWire
Tickers PLPL
News headline image
SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action
From Plandai Biotechnology
Via AccessWire
Topics Regulatory Compliance
Tickers PLPL
News headline image
Plandai Biotechnology In Non-Binding Letter of Intent to Acquire Rights to Puriblood’s Leukocyte Reduction Blood Filtration System with Plans to Address the International Blood Filtration Market
From Plandai Biotechnology
Via AccessWire
Tickers PLPL